Issue of Equity

26 Jan 2005 16:28

Akers Biosciences, Inc.26 January 2005 AKERS BIOSCIENCES, INC. ISSUE OF EQUITY Akers Biosciences, Inc. today announces that on 24 January 2005 it approved theissue of 36,885 shares of common stock, no par value ("Common Shares") toGeoffrey Vero, a non-executive director, which represents 0.08% of the totalshare capital. The shares will be issued in lieu of unpaid directors fees inthe amount of £22,500. The price per share for this transaction was 61 pence. Following this announcement, Mr. Vero is the beneficial owner of 186,885 commonshares representing 0.40% of the issued capital. Application has been made to the London Stock Exchange for the 36,885 CommonShares to be admitted to trading, such admission expected to take place on 31January 2005. Contact:Paul B. Freedman - 001 856 848 2116 This information is provided by RNS The company news service from the London Stock Exchange